FTC Sues Golden Sunrise Nutraceutical For Marketing COVID-19 Treatment Plan

The Federal Trade Commission has charged a California-based company with deceptively advertising a $23,000 treatment plan by saying it is scientifically proven to treat COVID-19. The FTC’s complaint claims Golden Sunrise began marketing its Emergency D-Virus plan as a COVID-19 treatment in March of this year. The company used billboards, websites, and social media to… Continue reading FTC Sues Golden Sunrise Nutraceutical For Marketing COVID-19 Treatment Plan

Exit mobile version